Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Non-Current Assets (2024 - 2025)

Historic Other Non-Current Assets for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $13.8 million.

  • Kura Oncology's Other Non-Current Assets rose 6739.95% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 6739.95%. This contributed to the annual value of $7.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Other Non-Current Assets is $13.8 million, which was up 6739.95% from $10.6 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Other Non-Current Assets ranged from a high of $13.8 million in Q3 2025 and a low of $7.4 million during Q2 2024